---
figid: PMC6072829__ott-11-4413Fig7
figtitle: Zyflamend and NFKB pathway
organisms:
- Armoracia rusticana
- Olea europaea
- Curcuma longa
- Zingiber officinale
- Scutellaria baicalensis
- Salvia rosmarinus
- Origanum vulgare
- Ocimum tenuiflorum
- Berberis vulgaris
- Homo sapiens
- Mus musculus
- Bos taurus
pmcid: PMC6072829
filename: ott-11-4413Fig7.jpg
figlink: /pmc/articles/PMC6072829/figure/f7-ott-11-4413/
number: F7
caption: 'Illustration of anticancer effect of Zyflamend against NFκB pathway in UBC
  cells.Abbreviations: UBC, urinary bladder cancer; NFκB, nuclear factor kappaB.'
papertitle: Combination chemotherapy with Zyflamend reduced the acquired resistance
  of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway.
reftext: Yanshi Xue, et al. Onco Targets Ther. 2018;11:4413-4429.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9034529
figid_alias: PMC6072829__F7
figtype: Figure
organisms_ner:
- Bos taurus
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC6072829__F7
ndex: e194343f-de8e-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6072829__ott-11-4413Fig7.html
  '@type': Dataset
  description: 'Illustration of anticancer effect of Zyflamend against NFκB pathway
    in UBC cells.Abbreviations: UBC, urinary bladder cancer; NFκB, nuclear factor
    kappaB.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - UBC
  - UBA52
  - BCL2
  - VEGFA
  - MYC
  - CCND1
  - MMP2
  - MMP9
  - Ubc
  - Uba52
  - Ubb
  - Rps27a
  - Nfkb1
  - Bcl2
  - Vegfa
  - Myc
  - Nol3
  - Ccnd1
  - Mmp2
  - Mmp9
  - RPS27A
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - Cisplatin
  - Cancer
---
